A Study of OV101 in Individuals With Fragile X Syndrome
Trial details
- Registry ID
- NCT03697161
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of OV101 in Individuals With Fragile X SyndromeNCT03697161 | OVID | Phase 2 | Completed | 2020-02-03Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |